Oxygen 99.7 % — Competitive Intelligence Brief

Oxygen 99.7 % (Oxygen 99.7 %) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Medical gas. Area: Respiratory / Critical Care.

phase 3 Medical gas Respiratory / Critical Care Small molecule

Target snapshot

Oxygen 99.7 % (Oxygen 99.7 %) — University of South Florida. Medical-grade oxygen at 99.7% purity provides supplemental oxygen to tissues to treat hypoxemia and improve oxygenation in patients with respiratory insufficiency.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Oxygen 99.7 % TARGET	Oxygen 99.7 %	University of South Florida	phase 3	Medical gas
Mix of 50% oxygen and 50% nitrogen	Mix of 50% oxygen and 50% nitrogen	Air Liquide Santé International	marketed	Medical gas
Standard Oxygen	Standard Oxygen	Central Denmark Region	marketed	Medical gas
Oxygen 40 %	Oxygen 40 %	George Papanicolaou Hospital	marketed	Medical gas / Respiratory therapeutic
normobaric oxygen with face mask	normobaric oxygen with face mask	Shahid Beheshti University of Medical Sciences	phase 3	Oxygen therapy / Medical gas
Аrgon-oxygen breathing mixture	Аrgon-oxygen breathing mixture	Negovsky Reanimatology Research Institute	phase 3	Medical gas mixture
Air/Oxygen	Air/Oxygen	Air Liquide Santé International	phase 3	Medical gas

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Medical gas class)

1. Air Liquide Santé International · 2 drugs in this class
2. Central Denmark Region · 1 drug in this class
3. University of South Florida · 1 drug in this class